Molecular Matrix
MMI: Innovating in stem cell research and bone regeneration technology since 2011.
Founded
2011MMI: Innovating in stem cell research and bone regeneration technology since 2011.
Molecular Matrix, Inc. (MMI) was founded in 2011 with a core mission to innovate in the field of tissue regeneration, particularly focusing on bone regeneration. The company's vision is to ensure that individuals worldwide have access to life-saving and life-enhancing treatments. MMI's primary product is a groundbreaking bone regeneration medical device, which has received FDA clearance after seven years of rigorous research and development. Their market focus includes stem cell research tools and advanced medical treatments for tissue regeneration.
Notable affiliated individuals include key researchers and scientists who have contributed to the development of their innovative platform technology. The company has achieved significant milestones, including FDA clearance for their bone regeneration device, marking a pivotal moment in their history. MMI's impact lies in its potential to revolutionize medical treatments for bone injuries and other regenerative applications, offering new hope and improved outcomes for patients globally.
Companies similar to Molecular Matrix include OsteoNovus, Tissue Regeneration Systems, EndoCellutions and MLM Biologics.
Molecular Matrix was founded in 2011.
Molecular Matrix's headquarters is located in West Sacramento, CA, US.
Molecular Matrix's most recent funding round was for $80k (USD) in January 2015.
As of Jan 26, 2015, Molecular Matrix has disclosed funding of $80k (USD). Undisclosed round amounts are excluded.
Molecular Matrix has 24 employees as of Feb 5, 2024.
MLM Biologics
mlmbiologics.com
